Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 08-2021 | 05-2021 | 02-2021 | 11-2020 | 08-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 1 | 86 | 69 | 97 |
| Receivables | 72 | 44 | 98 | 99 | 93 |
| Inventories | 0 | 0 | 0 | 3 | 53 |
| Other current assets | 1,007 | 1,122 | 0 | 0 | 0 |
| TOTAL | $1,087 | $1,175 | $192 | $180 | $259 |
| Non-Current Assets | |||||
| PPE Net | 0 | 27 | 72 | 78 | 120 |
| Intangibles | N/A | N/A | N/A | 0 | 580 |
| TOTAL | $0 | $27 | $72 | $78 | $700 |
| Total Assets | $1,087 | $1,202 | $264 | $257 | $960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,798 | 5,676 | 10,704 | 10,577 | 10,327 |
| Accounts payable and accrued liabilities | 756 | 715 | N/A | 2,788 | 2,681 |
| TOTAL | $6,555 | $6,392 | $13,253 | $13,421 | $13,065 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60 | 60 | 60 | 40 | 40 |
| TOTAL | $60 | $60 | $60 | $40 | $40 |
| Total Liabilities | $6,615 | $6,452 | $13,313 | $13,461 | $13,105 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,966 | N/A | N/A | N/A | N/A |
| Common Shares | 26,950 | 26,555 | 24,999 | 24,997 | 24,997 |
| Retained earnings | -43,423 | -43,341 | -48,225 | -48,207 | -47,136 |
| Other shareholders' equity | 1,876 | 2,467 | 1,118 | 1,046 | 1,319 |
| TOTAL | $-5,527 | $-5,250 | $-13,049 | $-13,204 | $-12,146 |
| Total Liabilities And Equity | $1,087 | $1,202 | $264 | $257 | $960 |